ERD

The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

The state of the art of islet transplantation and cell therapy in type 1 diabetes

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Cell Mass Increase Associated with Formation of Glucose‐Controlling β‐Cell Mass in Device‐Encapsulated Implants o...

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Biofabrication of a vascularized islet organ for type 1 diabetes

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Comparison of Omentum and Subcutis as Implant Sites for Device-Encapsulated Human iPSC-Derived Pancreatic Endoderm in Nu...

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Utility of Islet Cell Preparations From Donor Pancreases After Euthanasia

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Treating iPSC-Derived β Cells with an Anti-CD30 Antibody-Drug Conjugate Eliminates the Risk of Teratoma Development upo...

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Innate and adaptive immunity to human beta cell lines: implications for beta cell therapy

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Generation of β Cells from iPSC of a MODY8 Patient with a Novel Mutation in the Carboxyl Ester Lipase (CEL) Gene.

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Defining a cure for type 1 diabetes: a call to action

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Cell therapy for type 1 diabetes: from islet transplantation to stem cells.

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Transfer of stem cells and technology for further use in BetaCellTherapy program

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Encapsulated stem cell-derived β cells exert glucose control in patients with type 1 diabetes

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Transcriptional dynamics of induced pluripotent stem cell differentiation into β cells reveals full endodermal commitme...

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Assay using hu-iPS-PE-device generated beta cells identifies compounds with positive effect on functional human beta cel...

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Lower beta cell yield from donor pancreases after controlled circulatory death prevented by shortening acirculatory warm...

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

A viral link for type 1 diabetes

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Human beta cell preparations with QC data for comparative assessment of human iPS-derived implants in preclinical model ...

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Human beta cell grafts with QC data for start transplants in subgroup of type 1 diabetes recipients of VCTM implant

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Production of biodegradable microparticles for local release of VEGF, NGF and exenatide

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Communication network operational

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Defining outcomes for beta cell replacement therapy: a work in progress

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Warm ischemia time influences human islet cell isolation yield when assessed as beta cell number but not as islet equiva...

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Use of Culture to Reach Metabolically Adequate Beta-cell Dose by Combining Donor Islet Cell Isolates for Transplantation...

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacemen...

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

BetaCellTherapy website revised and updated

Project: BetaCellTherapy

Updated at: 29-04-2024

Show more information

Project acronym BetaCellTherapy

Resources

Selected filters:

The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes

The state of the art of islet transplantation and cell therapy in type 1 diabetes

Cell Mass Increase Associated with Formation of Glucose‐Controlling β‐Cell Mass in Device‐Encapsulated Implants o...

Biofabrication of a vascularized islet organ for type 1 diabetes

Comparison of Omentum and Subcutis as Implant Sites for Device-Encapsulated Human iPSC-Derived Pancreatic Endoderm in Nu...

Utility of Islet Cell Preparations From Donor Pancreases After Euthanasia

Treating iPSC-Derived β Cells with an Anti-CD30 Antibody-Drug Conjugate Eliminates the Risk of Teratoma Development upo...

Innate and adaptive immunity to human beta cell lines: implications for beta cell therapy

Generation of β Cells from iPSC of a MODY8 Patient with a Novel Mutation in the Carboxyl Ester Lipase (CEL) Gene.

Defining a cure for type 1 diabetes: a call to action

Cell therapy for type 1 diabetes: from islet transplantation to stem cells.

Transfer of stem cells and technology for further use in BetaCellTherapy program

Encapsulated stem cell-derived β cells exert glucose control in patients with type 1 diabetes

Transcriptional dynamics of induced pluripotent stem cell differentiation into β cells reveals full endodermal commitme...

Assay using hu-iPS-PE-device generated beta cells identifies compounds with positive effect on functional human beta cel...

Lower beta cell yield from donor pancreases after controlled circulatory death prevented by shortening acirculatory warm...

A viral link for type 1 diabetes

Human beta cell preparations with QC data for comparative assessment of human iPS-derived implants in preclinical model ...

Human beta cell grafts with QC data for start transplants in subgroup of type 1 diabetes recipients of VCTM implant

Production of biodegradable microparticles for local release of VEGF, NGF and exenatide

Communication network operational

Defining outcomes for beta cell replacement therapy: a work in progress

Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses

Warm ischemia time influences human islet cell isolation yield when assessed as beta cell number but not as islet equiva...

Use of Culture to Reach Metabolically Adequate Beta-cell Dose by Combining Donor Islet Cell Isolates for Transplantation...

US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?

Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacemen...

BetaCellTherapy website revised and updated